198 related articles for article (PubMed ID: 23633686)
21. Detection of Bioluminescent Borrelia burgdorferi from In Vitro Cultivation and During Murine Infection.
Hyde JA; Skare JT
Methods Mol Biol; 2018; 1690():241-257. PubMed ID: 29032549
[TBL] [Abstract][Full Text] [Related]
22. Cell division inhibitors with efficacy equivalent to isoniazid in the acute murine Mycobacterium tuberculosis infection model.
Knudson SE; Awasthi D; Kumar K; Carreau A; Goullieux L; Lagrange S; Vermet H; Ojima I; Slayden RA
J Antimicrob Chemother; 2015 Nov; 70(11):3070-3. PubMed ID: 26245639
[TBL] [Abstract][Full Text] [Related]
23. Measurements of vaccinia virus dissemination using whole body imaging: approaches for predicting of lethality in challenge models and testing of vaccines and antiviral treatments.
Zaitseva M; Kapnick S; Golding H
Methods Mol Biol; 2012; 890():161-76. PubMed ID: 22688767
[TBL] [Abstract][Full Text] [Related]
24. Highly sensitive in vivo imaging of Trypanosoma brucei expressing "red-shifted" luciferase.
McLatchie AP; Burrell-Saward H; Myburgh E; Lewis MD; Ward TH; Mottram JC; Croft SL; Kelly JM; Taylor MC
PLoS Negl Trop Dis; 2013 Nov; 7(11):e2571. PubMed ID: 24278497
[TBL] [Abstract][Full Text] [Related]
25. Using luciferase to image bacterial infections in mice.
Chang MH; Cirillo SL; Cirillo JD
J Vis Exp; 2011 Feb; (48):. PubMed ID: 21372790
[TBL] [Abstract][Full Text] [Related]
26. Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery.
Naran K; Moosa A; Barry CE; Boshoff HI; Mizrahi V; Warner DF
Antimicrob Agents Chemother; 2016 Nov; 60(11):6748-6757. PubMed ID: 27572410
[TBL] [Abstract][Full Text] [Related]
27. Generation and characterization of bioluminescent xenograft mouse models of MLL-related acute leukemias and in vivo evaluation of luciferase-targeting siRNA nanoparticles.
Fazzina R; Lombardini L; Mezzanotte L; Roda A; Hrelia P; Pession A; Tonelli R
Int J Oncol; 2012 Aug; 41(2):621-8. PubMed ID: 22665135
[TBL] [Abstract][Full Text] [Related]
28. Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase.
Palencia A; Li X; Bu W; Choi W; Ding CZ; Easom EE; Feng L; Hernandez V; Houston P; Liu L; Meewan M; Mohan M; Rock FL; Sexton H; Zhang S; Zhou Y; Wan B; Wang Y; Franzblau SG; Woolhiser L; Gruppo V; Lenaerts AJ; O'Malley T; Parish T; Cooper CB; Waters MG; Ma Z; Ioerger TR; Sacchettini JC; Rullas J; Angulo-Barturen I; Pérez-Herrán E; Mendoza A; Barros D; Cusack S; Plattner JJ; Alley MR
Antimicrob Agents Chemother; 2016 Oct; 60(10):6271-80. PubMed ID: 27503647
[TBL] [Abstract][Full Text] [Related]
29. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
30. Use of non-invasive bioluminescent imaging to assess mycobacterial dissemination in mice, treatment with bactericidal drugs and protective immunity.
Heuts F; Carow B; Wigzell H; Rottenberg ME
Microbes Infect; 2009 Dec; 11(14-15):1114-21. PubMed ID: 19682599
[TBL] [Abstract][Full Text] [Related]
31. Site-directed mutagenesis of firefly luciferase: implication of conserved residue(s) in bioluminescence emission spectra among firefly luciferases.
Tafreshi NKh; Sadeghizadeh M; Emamzadeh R; Ranjbar B; Naderi-Manesh H; Hosseinkhani S
Biochem J; 2008 May; 412(1):27-33. PubMed ID: 18251715
[TBL] [Abstract][Full Text] [Related]
32. Construction and evaluation of luciferase reporter phages for the detection of active and non-replicating tubercle bacilli.
Dusthackeer A; Kumar V; Subbian S; Sivaramakrishnan G; Zhu G; Subramanyam B; Hassan S; Nagamaiah S; Chan J; Paranji Rama N
J Microbiol Methods; 2008 Apr; 73(1):18-25. PubMed ID: 18272245
[TBL] [Abstract][Full Text] [Related]
33. A protein fragment of Rv3194c located on mycobacterial cell surface efficiently prevents adhesion of recombinant Mycobacterium smegmatis, and promises a new anti-adhesive drug.
Zhao D; Lin D; Xu C
Microb Pathog; 2020 Dec; 149():104498. PubMed ID: 32931894
[TBL] [Abstract][Full Text] [Related]
34. Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis.
Nikonenko BV; Samala R; Einck L; Nacy CA
Antimicrob Agents Chemother; 2004 Dec; 48(12):4550-5. PubMed ID: 15561824
[TBL] [Abstract][Full Text] [Related]
35. High-dose isoniazid therapy for isoniazid-resistant murine Mycobacterium tuberculosis infection.
Cynamon MH; Zhang Y; Harpster T; Cheng S; DeStefano MS
Antimicrob Agents Chemother; 1999 Dec; 43(12):2922-4. PubMed ID: 10582883
[TBL] [Abstract][Full Text] [Related]
36. A novel biosafety level 2 compliant tuberculosis infection model using a Δ
Asai M; Li Y; Spiropoulos J; Cooley W; Everest D; Robertson BD; Langford PR; Newton SM
Virulence; 2020 Dec; 11(1):811-824. PubMed ID: 32530737
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis.
Franzblau SG; DeGroote MA; Cho SH; Andries K; Nuermberger E; Orme IM; Mdluli K; Angulo-Barturen I; Dick T; Dartois V; Lenaerts AJ
Tuberculosis (Edinb); 2012 Nov; 92(6):453-88. PubMed ID: 22940006
[TBL] [Abstract][Full Text] [Related]
38. In vivo monitoring of DNA vaccine gene expression using firefly luciferase as a naked DNA.
Jeon YH; Choi Y; Kang JH; Chung JK; Lee YJ; Kim CW; Jeong JM; Lee DS; Lee MC
Vaccine; 2006 Apr; 24(16):3057-62. PubMed ID: 16483696
[TBL] [Abstract][Full Text] [Related]
39. Comparison of red-shifted firefly luciferase Ppy RE9 and conventional Luc2 as bioluminescence imaging reporter genes for in vivo imaging of stem cells.
Liang Y; Walczak P; Bulte JW
J Biomed Opt; 2012 Jan; 17(1):016004. PubMed ID: 22352654
[TBL] [Abstract][Full Text] [Related]
40. Reporter enzyme inhibitor study to aid assembly of orthogonal reporter gene assays.
Ho PI; Yue K; Pandey P; Breault L; Harbinski F; McBride AJ; Webb B; Narahari J; Karassina N; Wood KV; Hill A; Auld DS
ACS Chem Biol; 2013 May; 8(5):1009-17. PubMed ID: 23485150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
